{
    "title": "Mesoblast soars on U.S. FDA's nod to review lead therapy",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11833851/Mesoblast-soars-U-S-FDAs-nod-review-lead-drug-candidate.html",
    "date": "2023-03-08",
    "keywords": [
        "drug",
        "therapy",
        "disease",
        "march",
        "ltd",
        "wednesday",
        "food",
        "administration",
        "lead",
        "candidate",
        "priority",
        "basis",
        "remestemcell",
        "bone",
        "marrow",
        "blood",
        "need",
        "survival",
        "fda",
        "application",
        "response",
        "process",
        "health",
        "regulator",
        "decision",
        "aug",
        "line",
        "brokerage",
        "gmt",
        "jump",
        "onemonthhigh",
        "a1140",
        "session",
        "reporting",
        "savyata",
        "mishra",
        "bengaluru",
        "editing",
        "savio",
        "dsouza"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}